RCAN1 interferes with DRP1 activity, amplifying mitochondrial fragmentation, bioenergetic deficits, and oxidative stress and contributing to age-related neurodegeneration, including AD [72]. This evidence concerns the gene DNM1L and Alzheimer disease.